IRIS Accounts Production v24.3.0.553 06682721 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh066827212023-03-31066827212024-03-31066827212023-04-012024-03-31066827212022-03-31066827212022-04-012023-03-31066827212023-03-3106682721ns15:EnglandWales2023-04-012024-03-3106682721ns14:PoundSterling2023-04-012024-03-3106682721ns10:Director12023-04-012024-03-3106682721ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3106682721ns10:SmallEntities2023-04-012024-03-3106682721ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3106682721ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3106682721ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3106682721ns10:FullAccounts2023-04-012024-03-3106682721ns10:Director22023-04-012024-03-3106682721ns10:Director32023-04-012024-03-3106682721ns10:CompanySecretary12023-04-012024-03-3106682721ns10:RegisteredOffice2023-04-012024-03-3106682721ns5:CurrentFinancialInstruments2024-03-3106682721ns5:CurrentFinancialInstruments2023-03-3106682721ns5:ShareCapital2024-03-3106682721ns5:ShareCapital2023-03-3106682721ns5:RetainedEarningsAccumulatedLosses2024-03-3106682721ns5:RetainedEarningsAccumulatedLosses2023-03-3106682721ns5:LandBuildings2023-04-012024-03-3106682721ns5:PlantMachinery2023-04-012024-03-3106682721ns5:LandBuildings2023-03-3106682721ns5:PlantMachinery2023-03-3106682721ns5:LandBuildings2024-03-3106682721ns5:PlantMachinery2024-03-3106682721ns5:LandBuildings2023-03-3106682721ns5:PlantMachinery2023-03-3106682721ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3106682721ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3106682721ns5:RetainedEarningsAccumulatedLosses2023-03-3106682721ns5:RetainedEarningsAccumulatedLosses2023-04-012024-03-31
REGISTERED NUMBER: 06682721 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2024

for

FACEmed Limited

FACEmed Limited (Registered number: 06682721)






Contents of the Financial Statements
for the Year Ended 31 March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


FACEmed Limited

Company Information
for the Year Ended 31 March 2024







DIRECTORS: Miss M M Berrange
Mr C G Berrange
N J Baldock





SECRETARY: Miss M M Berrange





REGISTERED OFFICE:
1 Sopwith Crescent
Shotgate
Wickford
Essex
SS11 8YU





REGISTERED NUMBER: 06682721 (England and Wales)






FACEmed Limited (Registered number: 06682721)

Balance Sheet
31 March 2024

31.3.24 31.3.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 768,817 457,820

CURRENT ASSETS
Stocks 25,000 25,000
Debtors 5 43,649 127,006
Cash at bank and in hand 479,198 416,715
547,847 568,721
CREDITORS
Amounts falling due within one year 6 470,245 204,308
NET CURRENT ASSETS 77,602 364,413
TOTAL ASSETS LESS CURRENT
LIABILITIES

846,419

822,233

PROVISIONS FOR LIABILITIES 29,000 29,000
NET ASSETS 817,419 793,233

CAPITAL AND RESERVES
Called up share capital 21 21
Retained earnings 7 817,398 793,212
817,419 793,233

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

FACEmed Limited (Registered number: 06682721)

Balance Sheet - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 November 2024 and were signed on its behalf by:





Miss M M Berrange - Director


FACEmed Limited (Registered number: 06682721)

Notes to the Financial Statements
for the Year Ended 31 March 2024

1. STATUTORY INFORMATION

FACEmed Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Land and buildings - in accordance with the property
Plant and machinery etc - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

FACEmed Limited (Registered number: 06682721)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 8 (2023 - 12 ) .

4. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 April 2023 296,454 385,226 681,680
Additions 49,171 371,823 420,994
At 31 March 2024 345,625 757,049 1,102,674
DEPRECIATION
At 1 April 2023 12,209 211,651 223,860
Charge for year 10,002 99,995 109,997
At 31 March 2024 22,211 311,646 333,857
NET BOOK VALUE
At 31 March 2024 323,414 445,403 768,817
At 31 March 2023 284,245 173,575 457,820

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade debtors 18,294 4,432
Other debtors 25,355 122,574
43,649 127,006

FACEmed Limited (Registered number: 06682721)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade creditors 74,700 56,240
Taxation and social security 118,945 130,652
Other creditors 276,600 17,416
470,245 204,308

7. RESERVES
Retained
earnings
£   

At 1 April 2023 793,212
Profit for the year 594,336
Dividends (570,150 )
At 31 March 2024 817,398